Hand Osteoarthritis: Clinical Trials

7 trials for Hand Osteoarthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Not yet recruiting 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Hand Osteoarthritis: new trials by email Literature Review of Hand Osteoarthritis trials Research Report on Hand Osteoarthritis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis
Propionate de Clobétasol ( 0.05 %), Placebo - Hand Osteoarthritis
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris1872026-09-012026-09-10
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis
Phase 2 / Phase 3UnknownPeking University People's Hospital1502022-03-012022-02-08
Is Topical CBD Effective in Treating Thumb Joint Arthritis
CBD, Shea Butter - CBD, Hand Osteoarthritis
Phase 2CompletedUniversity of Virginia182020-07-282025-07-03
CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
Cannabidiol, Placebo Oral Tablet - Psoriatic Arthritis, Hand Osteoarthritis
Phase 2CompletedAalborg University Hospital1362018-11-282021-07-07
RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints
denosumab, Placebo, Calcium/Vit D supplementation - Hand Osteoarthritis
Phase 2CompletedUniversity Hospital, Ghent1002016-03-012024-09-25
Efficacy of Shinabro in Hand Osteoarthritis
Shinbaro, Placebo - Hand Osteoarthritis
Phase 2 / Phase 3CompletedSeoul National University Hospital2202013-09-012015-12-17
Splinting to Treat Hand Osteoarthritis
Splinting - Hand Osteoarthritis
Phase 2CompletedImperial College London452010-09-012016-02-17

Narrower conditions

Osteoarthritis (3)  ·  Arthritis (1)  ·  Arthritis, Psoriatic (1)  ·  Congenital Abnormalities (1)  ·  Marijuana Abuse (1)  ·  Pain (1)

Broader conditions

Joint Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Arthritis (3)  ·  Rheumatic Diseases (3)  ·  Bone Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Psoriasis (1)  ·  Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Papulosquamous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Cannabidiol (1)  ·  Denosumab (1)  ·  Splints (1)  ·  iguratimod (1)  ·  shinbaro (1)

Sponsors

Aalborg University Hospital (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Imperial College London (1)  ·  Peking University People's Hospital (1)  ·  Seoul National University Hospital (1)  ·  University Hospital, Ghent (1)  ·  University of Virginia (1)

Countries

Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

August Verbruggen, Prof Dr. Em. (1)  ·  Dirk Elewaut, Prof. Dr. (1)  ·  Eun Bong Lee, MD PhD (1)  ·  Fiona Watt (1)  ·  Jin Kyun Park, MD (1)  ·  Jonathan Vela (1)  ·  Kichul Shin, MD PhD (1)  ·  Ruth Wittoek, Prof. Dr. (1)  ·  Yun Jong Lee, MD PhD (1)

Results publications

PMID 24509405, PMID 27449412

NIH funding

2015 (1), 2025 (1)